SCHEMBL5722237

SCHEMBL5722237

COCc1cc2ccccn2c1C(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 5/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK1 P28482 4/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.40
ALOX12 P18054 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 3/20 0.40
ATM Q13315 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.38
KDM4E B2RXH2 1/20 0.38
RAB9A P51151 1/20 0.38
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11185205 0.73 MAPT (0.56) POLBMAPTSMN1; SMN2LMNAL3MBTL1
SCHEMBL14917192 0.72 ALDH1A1 (0.41) MAPTSMN1; SMN2CYP2C9CYP2C19ALDH1A1
SCHEMBL5722235 0.70 HTT (0.52) POLBMAPTSMN1; SMN2LMNACYP1A2
SCHEMBL11267717 0.69 MAPT (0.78) POLBMAPTSMN1; SMN2LMNAL3MBTL1
SCHEMBL11180555 0.69 L3MBTL1 (0.51) POLBMAPTSMN1; SMN2LMNAL3MBTL1
SCHEMBL11608011 0.69 MAPT (0.51) POLBMAPTSMN1; SMN2LMNAL3MBTL1
SCHEMBL11358475 0.67 KDM4E (0.53) POLBLMNAL3MBTL1CYP1A2CYP2D6
SCHEMBL6218670 0.67 ALDH1A1 (0.40) POLBMAPTSMN1; SMN2LMNAL3MBTL1
SCHEMBL1572767 0.67 HTT (0.54) POLBMAPTLMNACYP1A2CYP2D6
Isophthalic Acid SCHEMBL29023597 0.66 CA12 (0.60) POLBMAPTL3MBTL1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713543-A2 USE OF SUBSTITUTED 1,2,3 INDOLIZINE DERIVATIVES FOR TREATING DISEASES ASSOCIATED WITH A PATHOLOGICAL ANGIOGENESIS Sanofi-Aventis (FR) 2006-10-25 EP claimed
WO-2005082457-A2 USE OF SUBSTITUTED 1,2,3 INDOLIZINE DERIVATIVES FOR TREATING DISEASES ASSOCIATED WITH A PATHOLOGICAL CHOROIDAL ANGIOGENESIS SANOFI-AVENTIS (FR) 2005-09-09 WO claimed